Lantern Pharma Inc (LTRN)
6.13
-0.01
(-0.16%)
USD |
NASDAQ |
May 17, 16:00
6.00
-0.13
(-2.12%)
After-Hours: 20:00
Lantern Pharma Shares Outstanding: 10.76M for May 3, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 03, 2024 | 10.76M |
April 22, 2024 | 10.76M |
March 31, 2024 | 10.76M |
March 05, 2024 | 10.74M |
February 28, 2024 | 10.74M |
December 31, 2023 | 10.72M |
November 29, 2023 | 10.72M |
November 03, 2023 | 10.87M |
September 30, 2023 | 10.87M |
August 02, 2023 | 10.87M |
June 30, 2023 | 10.87M |
May 03, 2023 | 10.86M |
April 21, 2023 | 10.86M |
March 31, 2023 | 10.86M |
March 06, 2023 | 10.86M |
December 31, 2022 | 10.86M |
November 01, 2022 | 10.86M |
September 30, 2022 | 10.86M |
August 01, 2022 | 10.83M |
June 30, 2022 | 10.83M |
April 28, 2022 | 10.83M |
April 19, 2022 | 10.83M |
March 31, 2022 | 10.83M |
Date | Value |
---|---|
March 17, 2022 | 10.88M |
March 01, 2022 | 10.78M |
December 31, 2021 | 11.09M |
October 29, 2021 | 11.19M |
September 30, 2021 | 11.19M |
July 22, 2021 | 11.18M |
June 30, 2021 | 11.18M |
April 30, 2021 | 11.18M |
March 31, 2021 | 11.18M |
March 26, 2021 | 11.18M |
March 10, 2021 | 11.17M |
March 08, 2021 | 11.17M |
January 20, 2021 | 11.17M |
January 14, 2021 | 6.240M |
December 31, 2020 | 6.221M |
November 06, 2020 | 6.221M |
October 28, 2020 | 6.218M |
September 30, 2020 | 6.218M |
July 29, 2020 | 6.218M |
June 30, 2020 | 6.218M |
June 15, 2020 | 6.218M |
June 11, 2020 | 6.218M |
May 12, 2020 | 6.031M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
6.031M
Minimum
May 12 2020
11.19M
Maximum
Oct 29 2021
9.900M
Average
10.84M
Median
Shares Outstanding Benchmarks
Eyenovia Inc | 53.87M |
Cassava Sciences Inc | 47.98M |
Alpine Immune Sciences Inc | 68.60M |
Clearside Biomedical Inc | 74.73M |
Poseida Therapeutics Inc | 96.96M |